Dr.Surbhi Kansal, & Mainsha Jain. (2026). IN VITRO SUSCEPTIBILITY PROFILES OF FTOLOZANE–TAZOBACTAM AND CEFTAZIDIME–AVIBACTAM AGAINST AMPC/ ESBL PRODUCING ENTEROBACTERIACEAE. Journal of Population Therapeutics and Clinical Pharmacology, 33(2), 841-852. https://doi.org/10.69980/1gsrfr34